TY - JOUR
T1 - Ankle brachial pressure index but not brachial-ankle pulse wave velocity is a strong predictor of systemic atherosclerotic morbidity and mortality in patients on maintenance hemodialysis
AU - Tanaka, Miho
AU - Ishii, Hideki
AU - Aoyama, Toru
AU - Takahashi, Hiroshi
AU - Toriyama, Takanobu
AU - Kasuga, Hirotake
AU - Takeshita, Kyosuke
AU - Yoshikawa, Daiji
AU - Amano, Tetsuya
AU - Murohara, Toyoaki
PY - 2011/12
Y1 - 2011/12
N2 - Background: Ankle brachial pressure index (ABPI) and pulse wave velocity (PWV) have been widely recognized as a marker of systemic atherosclerosis. We examined whether ABPI and brachial-ankle PWV (baPWV) predict individual cardiovascular events in patients on maintenance hemodialysis (HD). Methods: We prospectively followed-up 445 HD patients undergoing both ABPI and baPWV measurements for up to 5 years. They were divided into 2 groups [group with ABPI >0.9 to ≤1.3 (n= 328) and group with ABPI ≤0.9 or >1.3 (n= 117)] and were also divided into tertiles according to the baPWV level (T1: <1850. cm/s; T2: 1850-2310. cm/s and T3: ≥2310. cm/s). Results: During the follow-up period (mean 43 ± 17 months), 206 cardiovascular events [cardiac event: 125 (28.1%), cerebrovascular events: 39 (8.8%), and peripheral arterial events: 42 (9.4%)] occurred, and 36 (8.1%) and 42 (9.4%) patients experienced cardiovascular and non-cardiovascular deaths, respectively. Cox multivariable analysis showed that presence of ABPI ≤0.9 or >1.3 was a significant predictor of cardiac events [hazard ratio (HR) 1.78, 95% confidential interval (CI) 1.27-2.49, p= 0.0008], cerebrovascular event (HR 1.95, 95%CI 1.13-3.36, p= 0.017), peripheral arterial event (HR 3.64, 95%CI 2.10-6.29, p< 0.0001), composite endpoint of cardiovascular events (HR 2.22, 95%CI 1.64-2.99, p< 0.0001), cardiovascular mortality (HR 2.42, 95%CI 1.44-4.06, p= 0.0008) and all-cause mortality (HR 1.52, 95%CI 1.03-2.25, p= 0.037). However, baPWV did not predict cardiovascular events on multivariate analysis. Conclusion: ABPI but not baPWV is useful for risk stratification of systemic atherosclerotic morbidity and mortality in HD patients. Furthermore, ABPI could predict not only individual peripheral arterial events but also cardiac and cerebrovascular events.
AB - Background: Ankle brachial pressure index (ABPI) and pulse wave velocity (PWV) have been widely recognized as a marker of systemic atherosclerosis. We examined whether ABPI and brachial-ankle PWV (baPWV) predict individual cardiovascular events in patients on maintenance hemodialysis (HD). Methods: We prospectively followed-up 445 HD patients undergoing both ABPI and baPWV measurements for up to 5 years. They were divided into 2 groups [group with ABPI >0.9 to ≤1.3 (n= 328) and group with ABPI ≤0.9 or >1.3 (n= 117)] and were also divided into tertiles according to the baPWV level (T1: <1850. cm/s; T2: 1850-2310. cm/s and T3: ≥2310. cm/s). Results: During the follow-up period (mean 43 ± 17 months), 206 cardiovascular events [cardiac event: 125 (28.1%), cerebrovascular events: 39 (8.8%), and peripheral arterial events: 42 (9.4%)] occurred, and 36 (8.1%) and 42 (9.4%) patients experienced cardiovascular and non-cardiovascular deaths, respectively. Cox multivariable analysis showed that presence of ABPI ≤0.9 or >1.3 was a significant predictor of cardiac events [hazard ratio (HR) 1.78, 95% confidential interval (CI) 1.27-2.49, p= 0.0008], cerebrovascular event (HR 1.95, 95%CI 1.13-3.36, p= 0.017), peripheral arterial event (HR 3.64, 95%CI 2.10-6.29, p< 0.0001), composite endpoint of cardiovascular events (HR 2.22, 95%CI 1.64-2.99, p< 0.0001), cardiovascular mortality (HR 2.42, 95%CI 1.44-4.06, p= 0.0008) and all-cause mortality (HR 1.52, 95%CI 1.03-2.25, p= 0.037). However, baPWV did not predict cardiovascular events on multivariate analysis. Conclusion: ABPI but not baPWV is useful for risk stratification of systemic atherosclerotic morbidity and mortality in HD patients. Furthermore, ABPI could predict not only individual peripheral arterial events but also cardiac and cerebrovascular events.
UR - http://www.scopus.com/inward/record.url?scp=82955163072&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=82955163072&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2011.09.037
DO - 10.1016/j.atherosclerosis.2011.09.037
M3 - Article
C2 - 22018643
AN - SCOPUS:82955163072
SN - 0021-9150
VL - 219
SP - 643
EP - 647
JO - Atherosclerosis
JF - Atherosclerosis
IS - 2
ER -